Condition
Chronic Kidney Diseases
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 200 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownAutomated Insulin Delivery in Adults With Advanced Kidney DiseaseNCT06463483 · 2025-11-01
RECRUITINGStreamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled HypertensionNCT07115953 · 2025-09-22
RECRUITINGSPYRAL GEMINI Pilot StudyNCT06907147 · 2025-05-01
RECRUITINGEpigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age PredictionNCT06953180 · 2025-03-03
RECRUITINGSafety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)NCT06752577 · 2024-12-22
RECRUITINGA Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health RecordNCT06642272 · 2024-10-10
RECRUITINGCare Transitions App for Patients With Multiple Chronic ConditionsNCT06051058 · 2024-10-08
RECRUITINGA Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly PatientsNCT06578078 · 2024-10-03
RECRUITINGGreen Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney DiseaseNCT06288204 · 2024-10-01
RECRUITINGImpact of Trans-catheter Aortic Valve Implantation on Renal FunctionNCT07626710 · 2024-08-30
RECRUITINGExploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney DiseaseNCT06322056 · 2024-05-13
RECRUITINGPharmacy-led Transitions of Care Intervention to Improve Medication AdherenceNCT06374277 · 2024-04-06
RECRUITINGPotassium Correction for RAAS Optimization in Chronic Kidney DiseaseNCT06256991 · 2024-04-01
RECRUITINGNephrospec SwitzerlandNCT06194591 · 2024-02-19
RECRUITINGKIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)NCT06153147 · 2024-01-05
RECRUITINGA Long-Term Follow-Up Study of Participants Exposed to REACTNCT05918523 · 2023-12-11
RECRUITINGA Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health DisparitiesNCT05321368 · 2023-10-16
RECRUITINGSodium Bicarbonate and Mitochondrial Energetics in Persons With CKDNCT04984226 · 2023-09-08
RECRUITINGPrevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaNCT05881447 · 2023-06-21
RECRUITINGMixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes MellitusNCT05692388 · 2023-01-23
RECRUITINGImproving the Collaborative Health of Adult DyadsNCT05370014 · 2023-01-03
RECRUITINGRisk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic DiseasesNCT05476627 · 2022-07-01
RECRUITINGInspiratory Muscle Strength Training in Chronic Kidney DiseaseNCT04911491 · 2022-03-01
RECRUITINGIntegrated Diagnosis and Treatment of CKD on OutcomesNCT05242055 · 2022-02-01
RECRUITINGSit Less, Interact and Move More (SLIMM) 2 StudyNCT05173714 · 2021-12-01
RECRUITINGDiabetic Nephropathy in People With Diabetes. Prevalence and Predictive FactorsNCT04916132 · 2021-08-10
RECRUITINGReal World Evidence Clinical Utility Study of KidneyIntelXNCT04802395 · 2021-03-02
RECRUITINGAmerican Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)NCT04185844 · 2020-08-31
RECRUITINGEMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health InequalityNCT03987633 · 2020-02-01
RECRUITINGKidney Precision Medicine ProjectNCT04334707 · 2019-09-01
RECRUITINGThe Role of Concomitant Diseases in Postoperative Complications Risk Stratification.NCT03945968 · 2019-07-01
RECRUITINGHome Hospital for Suddenly Ill AdultsNCT03524222 · 2018-01-18
RECRUITINGSubclinical Renal Dysfunction in Rheumatoid ArthritisNCT07805109 · 2026-09-01
NOT_YET_RECRUITINGNegative Pressure Wound Therapy Devices in Total Knee ArthroplastyNCT07770633 · 2026-09-01
NOT_YET_RECRUITINGFinerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney DiseaseNCT07667517 · 2026-07-01
NOT_YET_RECRUITINGKynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter StudyNCT07411937 · 2026-03-01
NOT_YET_RECRUITINGCheck@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney DiseaseNCT06330480 · 2025-05-14
ENROLLING_BY_INVITATIONChronotherapy in Children With Chronic Kidney DiseaseNCT05353335 · 2025-04-01
WITHDRAWNEffects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKDNCT06820567 · 2025-03-01
NOT_YET_RECRUITINGMobility Assessment in Multi-morbidityNCT06473168 · 2024-12-01
UNKNOWNPhysical Activity and Cardiovascular RiskNCT06440369 · 2024-09-01
NOT_YET_RECRUITINGTreatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical TrialNCT06094920 · 2024-07-29
COMPLETEDA Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney DiseaseNCT05286853 · 2024-07-17
WITHDRAWNEfficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease PatientsNCT06588465 · 2024-07-01
UNKNOWNSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney DiseaseNCT06190158 · 2024-05-15
ACTIVE_NOT_RECRUITINGmiRNA in Chronic Kidney DiseasesNCT06316284 · 2024-04-01
NOT_YET_RECRUITINGScreen CardRen - A Cross-sectional Observational Cohort StudyNCT06272578 · 2024-03-01
UNKNOWNEffect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseaseNCT05719714 · 2024-01-16
ACTIVE_NOT_RECRUITINGTunisian Clinical Registry on Chronic Kidney Disease in Hypertensive PatientsNCT05991089 · 2024-01-08
COMPLETEDAn Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With DementiaNCT05104593 · 2024-01-01
UNKNOWNNatriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney DiseaseNCT06203236 · 2024-01-01
UNKNOWNIntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.NCT06599424 · 2023-10-01
UNKNOWNTreating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot StudyNCT06094231 · 2023-09-25
TERMINATEDEffects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)NCT05887817 · 2023-09-07
UNKNOWNComparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney DiseaseNCT06344247 · 2023-09-01
UNKNOWNPatient Education Video to Reduce OTC NSAIDsNCT06575205 · 2023-08-02
UNKNOWNEFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURYNCT06288529 · 2023-07-15
COMPLETEDA Study of Participants With Chronic Kidney Disease Previously Treated With REACTNCT05694169 · 2023-07-11
TERMINATEDOptimizing In-hospital Use of Evidence-based Therapies for Patients With Cardio-Renal-Metabolic DiseaseNCT05781334 · 2023-06-09
COMPLETEDInteractive Computer-adaptive Chronic Kidney Disease Education ProgramNCT06364358 · 2023-05-31
UNKNOWNCommon interventions
PlaceboDRUG13Renal Autologous Cell Therapy (REACT)BIOLOGICAL4Community Health Navigator ProgramBEHAVIORAL3Empagliflozin 10 MGDRUG3Usual CareOTHER3Blood samplesBIOLOGICAL2Clinical and demographic dataOTHER2Continuous glucose monitoring (CGM) for four days.DEVICE2Dual Energy X-ray Absorptiometry (DEXA) scanRADIATION2Empagliflozin 25 MGDRUG2FinerenoneDRUG2Fruits and vegetables (F+V)OTHER2Hem-Col Capillary Blood Collection DeviceDIAGNOSTIC_TEST2Home Hospital careOTHER2Home hospitalizationOTHER2Kidney BiopsyPROCEDURE2KidneyIntelXDIAGNOSTIC_TEST2no interventionOTHER2PlaceboOTHER2SemaglutideDRUG2Sham ComparatorPROCEDURE2Withings BPM ConnectDEVICE210 week MySlainte ProgramBEHAVIORAL112-lead ECGDIAGNOSTIC_TEST124-hour ECG holter monitorDIAGNOSTIC_TEST1
Leading sponsors
Brigham and Women's Hospital
13
Prokidney
5
Assiut University
4
Duke University
4
University Medical Center Groningen
4
University of Calgary
4
Mayo Clinic
3
Medtronic Vascular
3
University of California, San Francisco
3
AstraZeneca
2
Baylor Research Institute
2
China Medical University Hospital
2
Copenhagen University Hospital, Rigshospitalet
2
Dacima Consulting
2
Donald Wesson
2
Trial status mix
COMPLETED88
UNKNOWN38
RECRUITING32
ACTIVE_NOT_RECRUITING10
TERMINATED9
WITHDRAWN9
NOT_YET_RECRUITING7
ENROLLING_BY_INVITATION4
SUSPENDED3
Phase mix
NA84
PHASE416
PHASE213
PHASE310
PHASE16
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.